Background
Knee osteoarthritis (OA) is a prevalent, progressive joint disorder characterized by pain, stiffness, and reduced function. Intra-articular injections are a key non-surgical intervention for patients with persistent symptoms despite conservative management. Two options include hyaluronic acid (HA) and the newer Arthrosamid hydrogel.
Treatment Comparison
| Aspect | Hyaluronic Acid (HA) | Arthrosamid Hydrogel |
|---|---|---|
| Mechanism | Temporary viscosupplementation mimicking synovial fluid | Integrates into synovium to cushion and reduce inflammation |
| Onset of Effect | Within weeks | Within weeks |
| Duration of Effect | 6 months | Up to 3 years (or more) |
| Frequency | Often requires repeat injections | Single injection |
| Pain Reduction | Moderate, short-term | Sustained, significant reduction (VAS scores) |
| Functional Improvement | Modest improvement in mobility and stiffness | Greater improvement (WOMAC scores) sustained over 12 months |
| Safety | Well-tolerated, mild post-injection flares | Well-tolerated, minor swelling, low incidence of synovitis |
| Cost Effectiveness | Lower upfront cost, but may need multiple doses | Higher upfront cost, but potentially lower long-term cost |
Clinical Recommendations
- Use Arthrosamid in patients with moderate to severe knee OA who have not responded to HA or prefer long-term symptom relief without frequent reinjections.
- Consider HA for patients preferring a more established, biodegradable option or those with mild OA needing short-term relief.
- Both agents are suitable for patients contraindicated for or declining surgery.
- Monitor for adverse events and counsel patients on expected onset and duration of effects.
- Further real-world studies are encouraged to assess Arthrosamid’s long-term safety and cost-effectiveness.
Summary
Arthrosamid offers a promising, long-lasting alternative to hyaluronic acid for improving pain and function in knee OA. It may be preferred in patients seeking durable relief from a single injection.